Previous 10 | Next 10 |
Shares of medical-device company InMode (NASDAQ: INMD) surged on Thursday after the company reported financial results for the second quarter of 2022. The company keeps beating expectations, and investors are celebrating it today. As of 3 p.m. ET, InMode stock was up 14%. In Q2,...
InMode Ltd. (INMD) Q2 2022 Earnings Conference Call July 28, 2022 08:30 AM ET Company Participants Miri Segal - Investor Relations, MS-IR LLC Moshe Mizrahy - Chairman and Chief Executive Officer Michael Kreindel - Chief Technology Officer & Director Yair ...
InMode 's (NASDAQ: INMD) shares are down around 60% so far this year, and its shareholders are having a very bumpy ride. However, it might not be difficult much longer. The medical-device manufacturer will report earnings for the second quarter on July 28, and all eyes are going to ...
InMode press release ( NASDAQ: INMD ): Q2 Non-GAAP EPS of $0.59 beats by $0.08 . Revenue of $113.55M (+30.0% Y/Y) beats by $10.55M . FY2022 Outlook : Revenues between $425M and $435M vs. consensus of $422.45M; Non-GAAP gross margin between 83% and 85%;...
InMode Reports Second Quarter 2022 Financial Results; Record Quarterly Revenue of $113.5M, Represents 30% Year-Over-Year Growth PR Newswire YOKNEAM, Israel , July 28, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") , a leading global provid...
InMode ( NASDAQ: INMD ) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open. The consensus EPS Estimate is $0.51 (-50.0% Y/Y) and the consensus Revenue Estimate is $103M (+18.0% Y/Y). Over the last 2 years, INMD has beaten EPS esti...
InMode raised full-year guidance, surprising market participants. We are very pleased with the company's operational development as internationalization progresses and recurring revenues increase. Asia and, in particular, China are catalysts for hyperbolic growth once pandemic-rel...
What's Working Begins This Week with Crypto; What's Not Working are Munis and the US Dollar. Earnings Season is Upon Us: Patterns Begin to Emerge. Our List of Bounce Back Candidates Begins with InMode (INMD). Brian Dress, CFA -- Director of Research, Investment Advisor...
Amid the declining share prices wrought by the bear market, there are tarnished treasures to find everywhere. It's shopping season for growth investors -- provided that you're willing to buy right when everyone else is selling, of course. In particular, InMode (NASDAQ: INMD) is ...
InMode to Present at the Canaccord 42nd Annual Growth Conference PR Newswire YOKNEAM, Israel , July 20, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...